1,381 results on '"Blobe, Gerard C."'
Search Results
2. The role of the extracellular matrix protein TGFBI in cancer
3. A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial)
4. Increased type III TGF-β receptor shedding decreases tumorigenesis through induction of epithelial-to-mesenchymal transition
5. Assessing the utility of molecular diagnostic classification for cancers of unknown primary
6. β-Arrestin 2 Mediates Endocytosis of Type III TGF-β Receptor and Down-Regulation of Its Signaling
7. Supplementary Figure S7 from Stromal Fibroblasts Mediate Anti–PD-1 Resistance via MMP-9 and Dictate TGFβ Inhibitor Sequencing in Melanoma
8. Supplementary Table 1 from Stromal Fibroblasts Mediate Anti–PD-1 Resistance via MMP-9 and Dictate TGFβ Inhibitor Sequencing in Melanoma
9. Data from Stromal Fibroblasts Mediate Anti–PD-1 Resistance via MMP-9 and Dictate TGFβ Inhibitor Sequencing in Melanoma
10. Supplementary Figure 1 from Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Dalantercept, an Activin Receptor–like Kinase-1 Ligand Trap, in Patients with Advanced Cancer
11. Supplementary Figure 2 from Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Dalantercept, an Activin Receptor–like Kinase-1 Ligand Trap, in Patients with Advanced Cancer
12. Data from Mechanical Stiffness Grades Metastatic Potential in Patient Tumor Cells and in Cancer Cell Lines
13. Data from The Type III Transforming Growth Factor-β Receptor as a Novel Tumor Suppressor Gene in Prostate Cancer
14. Supplementary Figure 5 from Mechanical Stiffness Grades Metastatic Potential in Patient Tumor Cells and in Cancer Cell Lines
15. Supplementary Figure 2 from Mechanical Stiffness Grades Metastatic Potential in Patient Tumor Cells and in Cancer Cell Lines
16. Supplementary Figure 1 from The Type III Transforming Growth Factor-β Receptor as a Novel Tumor Suppressor Gene in Prostate Cancer
17. Supplementary Figure 3 from Mechanical Stiffness Grades Metastatic Potential in Patient Tumor Cells and in Cancer Cell Lines
18. Supplementary Figure 4 from Mechanical Stiffness Grades Metastatic Potential in Patient Tumor Cells and in Cancer Cell Lines
19. Supplementary Figures 1-2 from Loss of Betaglycan Expression in Ovarian Cancer: Role in Motility and Invasion
20. Supplementary Figure 1 from Mechanical Stiffness Grades Metastatic Potential in Patient Tumor Cells and in Cancer Cell Lines
21. Supplementary Table 1 from Mechanical Stiffness Grades Metastatic Potential in Patient Tumor Cells and in Cancer Cell Lines
22. Phase I study of pazopanib plus TH-302 in advanced solid tumors
23. Emerging Roles of TGF-β Co-receptors in Human Disease
24. The Balance of Cell Surface and Soluble Type III TGF-β Receptor Regulates BMP Signaling in Normal and Cancerous Mammary Epithelial Cells
25. Heparan sulfate signaling in cancer
26. TGF-β Signaling : A Novel Target for Treatment of Breast Cancer?
27. Escape of Tumors From the Immune System : Role of the Transforming Growth Factor-ß-Signaling Pathway
28. Colorectal Cancer
29. Pancreatic Cancer
30. Angiotensin II stimulates canonical TGF-β signaling pathway through angiotensin type 1 receptor to induce granulation tissue contraction
31. Endocardial cell epithelial-mesenchymal transformation requires Type III TGFβ receptor interaction with GIPC
32. The Type III TGF-β Receptor Regulates Epithelial and Cancer Cell Migration through β-Arrestin2-Mediated Activation of Cdc42
33. Type III TGF-β Receptor Enhances Colon Cancer Cell Migration and Anchorage-Independent Growth
34. Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growth
35. Effects of the combination of TRC105 and bevacizumab on endothelial cell biology
36. Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer
37. Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs
38. Gfi-1B controls human erythroid and megakaryocytic differentiation by regulating TGF-β signaling at the bipotent erythro-megakaryocytic progenitor stage
39. Roles for the type III TGF-β receptor in human cancer
40. Proteoglycan signaling co-receptors: Roles in cell adhesion, migration and invasion
41. Type III TGF-[beta] receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma
42. Endoglin mediates fibronectin/α5β1 integrin and TGF‐β pathway crosstalk in endothelial cells
43. A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors
44. Endocytosis of the Type III Transforming Growth Factor-β (TGF-β) Receptor through the Clathrin-independent/Lipid Raft Pathway Regulates TGF-β Signaling and Receptor Down-regulation
45. Endoglin Promotes Transforming Growth Factor β-mediated Smad 1/5/8 Signaling and Inhibits Endothelial Cell Migration through Its Association with GIPC
46. A phase I study of bevacizumab (B) in combination with everolimus (E) and erlotinib (E) in advanced cancer (BEE)
47. Bone Morphogenetic Proteins Signal through the Transforming Growth Factor-β Type III Receptor
48. Role of transforming growth factor-β superfamily signaling pathways in human disease
49. The type III TGF-[beta] receptor regulates epithelial and cancer cell migration through [beta]-arrestin2-mediated activation of Cdc42
50. The Interaction of Endoglin with β-Arrestin2 Regulates Transforming Growth Factor-β-mediated ERK Activation and Migration in Endothelial Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.